Hypertension Drugs Market Share

North American Market Forecast

Hypertension drugs market in North America is predicted to account for the largest share of 30% by 2037, impelled by the presence of leading market players in the region that manufacture and market hypertension drugs. For instance, the presence of leading market players may result in the development of innovative drugs for hypertension and improved treatment options for patients in the region.

APAC Market Statistics

The APAC hypertension drugs market is estimated to be the second largest, during the forecast timeframe led by the rise in the geriatric population, especially in countries such as China, India, and Japan. The elderly population is more prone to chronic conditions such as high blood pressure which requires long-term management. This extended treatment period is expected to increase the demand for hypertension drugs in the region. According to the World Health Organization (WHO), owing to rising life expectancy and falling birth rates, 28% of China's population is expected to be over 60 by 2040.